Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.24B P/E 40.55 EPS this Y 26.00% Ern Qtrly Grth -68.60%
Income 147.28M Forward P/E 50.85 EPS next Y 27.40% 50D Avg Chg -10.00%
Sales 730.23M PEG 2.71 EPS past 5Y - 200D Avg Chg 4.00%
Dividend N/A Price/Book 16.17 EPS next 5Y 25.00% 52W High Chg -21.00%
Recommedations 2.90 Quick Ratio 10.61 Shares Outstanding 37.51M 52W Low Chg 46.00%
Insider Own 1.27% ROA 9.38% Shares Float 36.85M Beta 0.88
Inst Own 95.32% ROE 24.96% Shares Shorted/Prior 1.47M/1.79M Price 252.23
Gross Margin 86.94% Profit Margin 20.17% Avg. Volume 563,770 Target Price 316.14
Oper. Margin 21.96% Earnings Date May 6 Volume 408,157 Change -2.90%
About ShockWave Medical, Inc.

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

ShockWave Medical, Inc. News
04/25/24 Why the Market Dipped But Shockwave Medical (SWAV) Gained Today
04/24/24 Shockwave Medical (SWAV) Rose on an Acquisition News and Solid Financial Result
04/23/24 Why Investors Need to Take Advantage of These 2 Medical Stocks Now
04/21/24 11 Best Low Price Pharma Stocks To Invest In
04/19/24 Shockwave Medical (SWAV) Advances While Market Declines: Some Information for Investors
04/16/24 Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
04/16/24 J&J CFO on Q1 Earnings, Forecast and Product Pipeline
04/16/24 ‘We think in decades’: J&J’s $30B spending spree may not be over
04/15/24 Why Shockwave Medical (SWAV) Could Beat Earnings Estimates Again
04/12/24 Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
04/12/24 Shockwave Medical (SWAV) Rose on Strong Financial Results
04/10/24 Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024
04/10/24 Top 5 Non-Tech Nasdaq Winners of Q1 With More Upside Left
04/10/24 Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
04/09/24 Shockwave Medical's (SWAV) Reducer Receives Positive Results
04/08/24 Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study
04/08/24 J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio
04/06/24 Can a New CEO Fix Boeing?
04/05/24 What’s News: Business & Finance
04/05/24 Johnson & Johnson Ends The Shockwave Rumor Mill With $13.1 Billion Takeover
SWAV Chatroom

User Image shan116 Posted - 1 day ago

@Stockpicks1017 stock doesn’t work like that. If MM not sure about what happens with this stock , they ll be out of the stock as they have hell of lot of other stocks to play with. I did traded in the past like $SWAV and all will come into life based on some news doesn’t matter puts or calls.

User Image intratio Posted - 1 day ago

$SWAV https://www.intratio.com/stock-forecast/SWAV Our trained A.I. is making the inference that the price of this stock will decrease quickly and will have a negative trend in the upcoming months

User Image intratio Posted - 2 days ago

$SWAV https://www.intratio.com/stock-forecast/SWAV Shockwave Medical, Inc. The trained A.I judges this company s stock price has a bad setup for the short run and has a dismal outlook for the future

User Image TJmaximus Posted - 2 days ago

$SWAV

User Image intratio Posted - 3 days ago

https://www.intratio.com/stock-forecast/SWAV Shockwave Medical, Inc. The model has detected that the stock price of this company will not increase any time soon and has low expectations for the future $SWAV

User Image TJmaximus Posted - 3 days ago

$SWAV https://x.com/ShockwaveIVL/status/1782425186735992848

User Image intratio Posted - 6 days ago

Shockwave Medical, Inc. The trained model has forecasted the price action of this stock will shortly go down and is not very optimistic about the future $SWAV

User Image Maverick11 Posted - 6 days ago

$VKTX Merger Monday?.. options sure acting like it. The big bio deals are often “out there”. $JNJ $SWAV was rumored for a while before coming to fruition. This and $PFE makes a whole lot of sense… among other suitors… let’s see… Mav

User Image TJmaximus Posted - 6 days ago

$SWAV

User Image Mergerbrief Posted - 1 week ago

$SWAV $JNJ - HSR File By Date MergerBrief.com

User Image Gbpfan1212 Posted - 1 week ago

$SWAV so when do we get the cash?

User Image heyyo11 Posted - 1 week ago

$PRCT Fred Moll selling $SWAV should bring focus back to $PRCT

User Image Maverick11 Posted - 1 week ago

$VKTX 250 more. I can’t help myself @ 66.74. Reminds me of $SWAV where I was in below $200 as messages show… you knew $JNJ was buying them. It made sense/was out there. The same way $PFE is buying this. The Board there should oust management if this deal isn’t being actively finalized at present. Big Pharma is lapping $PFE presently… Mav

User Image Its_Me_Smeagol Posted - 2 weeks ago

$RLYB soooo $JNJ acquired ABIOMED in 2022…now they’re buying $SWAV for $16B……….and they just collaborated with $RLYB there’s a connection somewhere……hmmmmmm maybe a BUYOUT of RLYB on the horizon as well……all I know, IM LOCKKKKKKKED AND LOADEDDDDDDDDD!!!!!

User Image TJmaximus Posted - 2 weeks ago

$SWAV easy $$$ from 325, where are the clowns who mocked the play?

User Image TJmaximus Posted - 2 weeks ago

$SWAV BOOM...

User Image TJmaximus Posted - 2 weeks ago

$SWAV https://www.globenewswire.com/news-release/2024/04/10/2860819/0/en/SWAV-Alert-Monsey-Firm-of-Wohl-Fruchter-Investigating-Fairness-of-the-Sale-of-Shockwave-Medical-to-Johnson-Johnson.html

User Image TJmaximus Posted - 2 weeks ago

$SWAV https://x.com/ShockwaveIVL/status/1777735845761761640

User Image TJmaximus Posted - 2 weeks ago

$SWAV I am petitioning for a higher buyout price.

User Image TJmaximus Posted - 2 weeks ago

$SWAV https://www.businesswire.com/news/home/20240408057780/en/SHOCKWAVE-MEDICAL-INVESTOR-ALERT-by-the-Former-Attorney-General-of-Louisiana-Kahn-Swick-Foti-LLC-Investigates-Adequacy-of-Price-and-Process-in-Proposed-Sale-of-Shockwave-Medical-Inc.---SWAV

User Image DonCorleone77 Posted - 2 weeks ago

$SWAV 2 of 2 - ShockWave Medical data confirm consistent 'real-world' outcomes ...."Results from the REDUCER-I study continue to demonstrate the safety and effectiveness of Shockwave Coronary Sinus Reducer as a novel therapy for refractory angina," said Dr. Verheye. "We observed consistent reduction in symptoms of refractory angina and improvements in quality of life, results which align with those from the COSIRA study, previously published in The New England Journal of Medicine, in a challenging patient cohort characterized by high rates of cardiovascular risk factors and coexisting comorbidities for whom there have historically been no other treatment options."

User Image DonCorleone77 Posted - 2 weeks ago

$SWAV 1 of 2 - ShockWave Medical data confirm consistent 'real-world' outcomes Shockwave Medical announced that investigators presented six-month data from the full population of the REDUCER-I study, alongside interim long-term follow-up results to three years. These findings confirm the positive, 'real-world' outcomes of Shockwave Reducer, a novel technology for the treatment of refractory angina. ...The primary effectiveness endpoint for the study was the percentage of patients experiencing improvement in their symptoms of angina defined as a reduction in Canadian Cardiovascular Society grade at six months compared with baseline. The primary safety endpoints were the rate of device- and/or procedure-related periprocedural serious adverse events and major adverse cardiac events up to 30 days post implant....

User Image TJmaximus Posted - 2 weeks ago

$SWAV This news alone would have sent the stock up $10, f*ck: https://ir.shockwavemedical.com/news-releases/news-release-details/shockwave-reducer-demonstrates-consistent-positive-results-real

User Image Stock_Titan Posted - 2 weeks ago

$SWAV Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study https://www.stocktitan.net/news/SWAV/shockwave-reducer-demonstrates-consistent-positive-results-in-real-uqxf1l6m1c0s.html

User Image Thestocktraderhubzee Posted - 2 weeks ago

$SWAV Deutsche Bank Downgrades Shockwave Medical to Hold, Raises Price Target to $335

User Image IN0V8 Posted - 2 weeks ago

$SWAV Canaccord Genuity cuts to hold from buy Canaccord Genuity raises target price to $335 from $263 Deutsche Bank cuts to hold from buy Deutsche Bank raises target price to $335 from $270 Leerink Partners cuts target price to $335 from $361 Leerink Partners cuts to market perform from outperform Needham cuts to hold from buy

User Image SqueezeFinder1 Posted - 2 weeks ago

Good morning all, it's a quiet day in the markets but I'm ready for more selling in case the downtrend continues. I'm watching 446 on the Q's, a close above that would be a breakout and a return to bullishness. Here are a couple of ideas in the meantime: - $SAVA is up nicely today, and scores are looking good. Any positive news could give us a squeeze on this one - $IMPP I took an opener on Friday, and this one fired an alert today so let's keep on close watch - $SWAV I made a downside bet using the ShortFinder database, let's see if we get a pullback on this one soon Check my profile for more info :)

User Image TJmaximus Posted - 2 weeks ago

$SWAV I would welcome the deal to stall out...

User Image CaptJrod Posted - 2 weeks ago

$SWAV Take profits now or waiting for the $335 per share in cash?

User Image muldoon92 Posted - 2 weeks ago

$TMDX #1 stock most excited about in port. Planning to transition majority of $SWAV winnings here. Everything here feels like the best available high growth medtech play now that Shockwave is off the table… very boolish

Analyst Ratings
CL King Neutral Apr 8, 24
Leerink Partners Market Perform Apr 8, 24
Deutsche Bank Hold Apr 8, 24
Morgan Stanley Equal-Weight Apr 8, 24
Canaccord Genuity Hold Apr 5, 24
Needham Hold Apr 5, 24
Wolfe Research Peer Perform Apr 5, 24
Piper Sandler Overweight Apr 2, 24
CL King Buy Mar 27, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Feb 05 Sell 230.7 3,229 744,930 21,005 02/06/24
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 229.92 3,406 783,108 27,732 02/02/24
Zacharias Isaac President, CCO President, CCO Jan 26 Sell 224.69 4,000 898,760 63,920 01/29/24
Zacharias Isaac President, CCO President, CCO Jan 26 Option 6.71 4,000 26,840 67,920 01/29/24
Godshall Douglas Evan President & CEO President & CEO Jan 16 Sell 217.93 10,000 2,179,300 141,057 01/18/24
Godshall Douglas Evan President & CEO President & CEO Jan 16 Option 3.42 10,000 34,200 151,057 01/18/24
Zacharias Isaac President, CCO President, CCO Jan 12 Option 5.37 17,921 96,236 63,920 01/17/24
WATKINS FRANK T Director Director Jan 08 Sell 198.09 2,000 396,180 4,532 01/10/24
WATKINS FRANK T Director Director Jan 08 Option 3.42 2,000 6,840 6,532 01/10/24
Godshall Douglas Evan President & CEO President & CEO Jan 05 Sell 200.05 10,000 2,000,500 141,057 01/08/24
Godshall Douglas Evan President & CEO President & CEO Jan 05 Option 3.42 10,000 34,200 151,057 01/08/24
WATKINS FRANK T Director Director Jun 20 Option 3.416 3,000 10,248 4,532 01/04/24
Zacharias Isaac President, CCO President, CCO Dec 26 Sell 192.5 4,000 770,000 41,606 12/28/23
Zacharias Isaac President, CCO President, CCO Dec 26 Option 6.71 3,458 23,203 45,606 12/28/23
Godshall Douglas Evan President & CEO President & CEO Dec 15 Sell 188.79 5,000 943,950 141,057 12/18/23
Godshall Douglas Evan President & CEO President & CEO Dec 15 Option 3.42 5,000 17,100 146,057 12/18/23
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Dec 08 Sell 173.88 200 34,776 28,784 12/11/23
Phung Trinh VP, Finance VP, Finance Dec 07 Sell 171.63 203 34,841 29,037 12/08/23
Zacharias Isaac President, CCO President, CCO Nov 27 Sell 173.58 4,000 694,320 43,868 11/28/23
Zacharias Isaac President, CCO President, CCO Nov 27 Option 6.71 3,777 25,344 47,868 11/28/23
WATKINS FRANK T Director Director Nov 20 Sell 173.11 3,000 519,330 1,532 11/21/23
WATKINS FRANK T Director Director Nov 20 Option 3.42 3,000 10,260 4,532 11/21/23
Godshall Douglas Evan President & CEO President & CEO Nov 15 Sell 174.38 5,000 871,900 136,057 11/17/23
Godshall Douglas Evan President & CEO President & CEO Nov 15 Option 3.42 5,000 17,100 141,057 11/17/23
Phung Trinh VP, Finance VP, Finance Apr 26 Option 3.42 2,400 8,208 31,095 11/03/23
Zacharias Isaac President, CCO President, CCO Oct 26 Sell 210.25 4,000 841,000 44,316 10/30/23
Zacharias Isaac President, CCO President, CCO Oct 26 Option 6.71 411 2,758 48,316 10/30/23
WATKINS FRANK T Director Director Oct 20 Sell 203.14 3,000 609,420 1,532 10/23/23
WATKINS FRANK T Director Director Oct 20 Option 3.42 3,000 10,260 4,532 10/23/23
Godshall Douglas Evan President & CEO President & CEO Oct 16 Sell 199.71 10,000 1,997,100 141,649 10/17/23
Godshall Douglas Evan President & CEO President & CEO Oct 16 Option 3.42 10,000 34,200 151,649 10/17/23
Zacharias Isaac President, CCO President, CCO Sep 26 Sell 192.12 4,000 768,480 47,905 09/27/23
WATKINS FRANK T Director Director Sep 20 Sell 209.23 3,000 627,690 1,532 09/21/23
WATKINS FRANK T Director Director Sep 20 Option 3.42 3,000 10,260 4,532 09/21/23
Godshall Douglas Evan President & CEO President & CEO Sep 15 Sell 212.62 10,000 2,126,200 141,649 09/19/23
Godshall Douglas Evan President & CEO President & CEO Sep 15 Option 3.42 10,000 34,200 151,649 09/19/23
Phung Trinh VP, Finance VP, Finance Aug 29 Option 3.416 5,000 17,080 25,986 08/31/23
Zacharias Isaac President, CCO President, CCO Aug 25 Sell 204.98 4,000 819,920 52,446 08/29/23
Godshall Douglas Evan President & CEO President & CEO Aug 24 Sell 212.95 10,000 2,129,500 141,649 08/25/23
Godshall Douglas Evan President & CEO President & CEO Aug 24 Option 3.42 10,000 34,200 151,649 08/25/23
FRANCIS LAURA Director Director Aug 22 Sell 220.97 497 109,822 3,054 08/23/23
WATKINS FRANK T Director Director Aug 21 Sell 218.97 3,000 656,910 1,532 08/22/23
WATKINS FRANK T Director Director Aug 21 Option 3.42 3,000 10,260 4,532 08/22/23
Toyloy Sara Director Director Aug 15 Sell 223.64 100 22,364 3,673 08/16/23
Zacharias Isaac President, CCO President, CCO Jul 26 Sell 268.06 4,000 1,072,240 56,678 07/27/23
WATKINS FRANK T Director Director Jul 20 Sell 267.11 3,000 801,330 1,532 07/21/23
WATKINS FRANK T Director Director Jul 20 Option 3.42 3,000 10,260 4,532 07/21/23
Papiernik Antoine Director Director Jul 05 Option 17.00 17,381 295,477 22,662 07/06/23
Zacharias Isaac President, CCO President, CCO Jun 26 Sell 291.84 4,000 1,167,360 60,678 06/26/23
Phung Trinh VP, Finance VP, Finance Jun 22 Sell 295.91 62 18,346 21,101 06/26/23